Nuzenio

Nuvectis Pharma Reports

Nuvectis Pharma Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Soleus group (NVCT) discloses 1.65M-share, 5.1% Nuvectis Pharma stake - Stock TitanStock Titan · Thu, 06 Aug 2026 15:20:09 GMTNuvectis Pharma (NASDAQ:NVCT) Shares Gap Down After Earnings Miss - MarketBeatMarketBeat · Tue, 04 Aug 2026 14:49:11 GMTNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:35:23 GMTNuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:11:01 GMTNuvectis Pharma (NASDAQ: NVCT) boosts cash with $115M stock sale and new drug licenses - Stock TitanStock Titan · Tue, 04 Aug 2026 13:02:10 GMTNuvectis Reports $7.0 Million Q2 Net Loss After Pipeline Deals - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 12:31:00 GMTNuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMT

Timeline

Thu, 06 Aug 2026 15:20:09 GMTSoleus group (NVCT) discloses 1.65M-share, 5.1% Nuvectis Pharma stake - Stock Titan
Tue, 04 Aug 2026 14:49:11 GMTNuvectis Pharma (NASDAQ:NVCT) Shares Gap Down After Earnings Miss - MarketBeat
Tue, 04 Aug 2026 13:35:23 GMTNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Tue, 04 Aug 2026 13:11:01 GMTNuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary - TradingView
Tue, 04 Aug 2026 13:02:10 GMTNuvectis Pharma (NASDAQ: NVCT) boosts cash with $115M stock sale and new drug licenses - Stock Titan
Tue, 04 Aug 2026 12:31:00 GMTNuvectis Reports $7.0 Million Q2 Net Loss After Pipeline Deals - Quiver Quantitative

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nuvectis Pharma Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.